Epstein David R — SEC insider filings
SEC reporting owner CIK 1445826. 69 insider filings on record with FilingPulse; latest filed 2026-11-19.
Transaction summary — filings shown
Covers the 50 most recent of 69 filings on record, filed 2021-11-22 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 16 legs across 9 filings — 133,281 shares, $558,008 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 17 legs across 17 filings — 16,570 shares, $2,600,094 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 69.
- Largest priced transaction: sale of 10,620 shares @ $213.01 ($2,262,166) in Seagen Inc., filed 2023-11-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Seagen Inc. (SGEN) | CEO, Director | 4 | — | 1 leg · 10,620 sh · $2,262,166 | 17 |
| AgomAb Therapeutics NV (AGMB) | Director | 6 | 13 legs · 59,980 sh · $439,679 | — | — |
| Tempus AI, Inc. (TEM) | Director | 19 | — | 16 legs · 5,950 sh · $337,927 | 3 |
| Axcella Health Inc. (AXLA) | Director | 7 | 1 leg · 26,178 sh · $50,000 | — | 12 |
| Rubius Therapeutics, Inc. (RUBY) | Director | 2 | 1 leg · 30,000 sh · $43,329 | — | 1 |
| Evelo Biosciences, Inc. (EVLO) | Director | 10 | 1 leg · 17,123 sh · $25,000 | — | 33 |
| Senti Biosciences, Inc. (SNTI) | Director | 2 | — | — | 3 |
Insider filings — Epstein David R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-19 | 4 | AgomAb Therapeutics NV (AGMB) | Purchase (P): 5,000 @ $5.57 | EDGAR |
| 2026-11-16 | 4 | AgomAb Therapeutics NV (AGMB) | Purchase (P): 5,000 @ $5.99 · Purchase (P): 20 @ $6 · Purchase (P): 5,000 @ $5.75 · Purchase (P): 4,960 @ $6.02 | EDGAR |
| 2026-11-06 | 4 | AgomAb Therapeutics NV (AGMB) | Purchase (P): 5,000 @ $6.81 · Purchase (P): 5,000 @ $6.91 · Purchase (P): 5,000 @ $6.98 | EDGAR |
| 2026-11-04 | 4 | Tempus AI, Inc. (TEM) | Sale (S): 370 @ $74.29 | EDGAR |
| 2026-10-22 | 4 | AgomAb Therapeutics NV (AGMB) | Purchase (P): 5,000 @ $8.86 · Purchase (P): 5,000 @ $8.90 | EDGAR |
| 2026-10-09 | 4 | AgomAb Therapeutics NV (AGMB) | Purchase (P): 5,000 @ $8.90 | EDGAR |
| 2026-10-07 | 4 | AgomAb Therapeutics NV (AGMB) | Purchase (P): 5,000 @ $8.57 · Purchase (P): 5,000 @ $8.70 | EDGAR |
| 2026-09-03 | 4 | Tempus AI, Inc. (TEM) | Sale (S): 250 @ $65.55 | EDGAR |
| 2026-08-05 | 4 | Tempus AI, Inc. (TEM) | Sale (S): 370 @ $43.40 | EDGAR |
| 2026-06-03 | 4 | Tempus AI, Inc. (TEM) | Sale (S): 250 @ $49.40 | EDGAR |
| 2026-05-26 | 4 | Tempus AI, Inc. (TEM) | Grant/award (A): 5,913 @ $0 | EDGAR |
| 2026-03-04 | 4 | Tempus AI, Inc. (TEM) | Sale (S): 250 @ $50.69 | EDGAR |
| 2026-02-04 | 4 | Tempus AI, Inc. (TEM) | Sale (S): 370 @ $59.41 | EDGAR |
| 2025-12-03 | 4 | Tempus AI, Inc. (TEM) | Sale (S): 250 @ $75.55 | EDGAR |
| 2025-11-05 | 4 | Tempus AI, Inc. (TEM) | Sale (S): 370 @ $90 | EDGAR |
| 2025-09-04 | 4 | Tempus AI, Inc. (TEM) | Sale (S): 250 @ $73.64 | EDGAR |
| 2025-08-05 | 4 | Tempus AI, Inc. (TEM) | Sale (S): 370 @ $55.16 | EDGAR |
| 2025-06-04 | 4 | Tempus AI, Inc. (TEM) | Sale (S): 250 @ $55.20 | EDGAR |
| 2025-05-22 | 4 | Tempus AI, Inc. (TEM) | Grant/award (A): 1,997 @ $0 | EDGAR |
| 2025-05-05 | 4 | Tempus AI, Inc. (TEM) | Sale (S): 370 @ $53.50 | EDGAR |
| 2025-03-19 | 4 | Tempus AI, Inc. (TEM) | Sale (S): 990 @ $46.83 | EDGAR |
| 2025-03-05 | 4 | Tempus AI, Inc. (TEM) | Sale (S): 250 @ $57.52 | EDGAR |
| 2025-02-05 | 4 | Tempus AI, Inc. (TEM) | Sale (S): 370 @ $53.31 | EDGAR |
| 2024-12-13 | 4 | Tempus AI, Inc. (TEM) | Sale (S): 620 @ $41.81 | EDGAR |
| 2024-06-17 | 4 | Tempus AI, Inc. (TEM) | Grant/award (A): 28,514 @ $0 | EDGAR |
| 2023-12-15 | 4 | Seagen Inc. (SGEN) | Disposition to issuer (D): 16,407 @ $229 · Disposition to issuer (D): 2,896 (derivative) · Disposition to issuer (D): 240,451 (derivative) · Disposition to issuer (D): 224,000 (derivative) · Disposition to issuer (D): 80,541 (derivative) · Disposition to issuer (D): 39,650 (derivative) · +6 more | EDGAR |
| 2023-11-13 | 4 | Seagen Inc. (SGEN) | Sale (S): 10,620 @ $213.01 | EDGAR |
| 2023-08-17 | 4 | Seagen Inc. (SGEN) | Grant/award (A): 39,650 @ $0 | EDGAR |
| 2022-11-14 | 4 | Seagen Inc. (SGEN) | Grant/award (A): 107,389 @ $0 · Grant/award (A): 2,896 (derivative) @ $0 · Grant/award (A): 240,451 (derivative) @ $0 · Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2022-07-15 | 4 | Senti Biosciences, Inc. (SNTI) | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2022-06-30 | 4 | Evelo Biosciences, Inc. (EVLO) | Option exercise (M): 2,053 @ $0 · Option exercise (M): 2,874 @ $0 · Option exercise (M): 2,053 (derivative) @ $0 · Option exercise (M): 2,874 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | Evelo Biosciences, Inc. (EVLO) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | Dynamics Special Purpose Corp. (SNTI) | Grant/award (A): 112,519 @ $0 · Option exercise (M): 112,519 (derivative) | EDGAR |
| 2022-06-03 | 4 | Axcella Health Inc. (AXLA) | Grant/award (A): 47,059 @ $0 | EDGAR |
| 2022-06-01 | 4 | Evelo Biosciences, Inc. (EVLO) | Option exercise (M): 2,052 @ $0 · Option exercise (M): 2,873 @ $0 · Option exercise (M): 2,052 (derivative) @ $0 · Option exercise (M): 2,873 (derivative) @ $0 | EDGAR |
| 2022-05-31 | 4 | Evelo Biosciences, Inc. (EVLO) | Purchase (P): 17,123 @ $1.46 | EDGAR |
| 2022-05-13 | 4 | Rubius Therapeutics, Inc. (RUBY) | Grant/award (A): 499,762 (derivative) @ $0 | EDGAR |
| 2022-05-02 | 4 | Evelo Biosciences, Inc. (EVLO) | Option exercise (M): 2,053 @ $0 · Option exercise (M): 2,873 @ $0 · Option exercise (M): 2,053 (derivative) @ $0 · Option exercise (M): 2,873 (derivative) @ $0 | EDGAR |
| 2022-04-22 | 4 | Rubius Therapeutics, Inc. (RUBY) | Purchase (P): 30,000 @ $1.44 | EDGAR |
| 2022-04-01 | 4 | Evelo Biosciences, Inc. (EVLO) | Option exercise (M): 2,052 @ $0 · Option exercise (M): 2,874 @ $0 · Option exercise (M): 2,052 (derivative) @ $0 · Option exercise (M): 2,874 (derivative) @ $0 | EDGAR |
| 2022-03-21 | 4 | Axcella Health Inc. (AXLA) | Option exercise (M): 1,535 · Grant/award (A): 50,000 (derivative) @ $0 · Option exercise (M): 1,535 (derivative) @ $0 | EDGAR |
| 2022-03-18 | 4 | Axcella Health Inc. (AXLA) | Purchase (P): 26,178 @ $1.91 | EDGAR |
| 2022-03-01 | 4 | Evelo Biosciences, Inc. (EVLO) | Option exercise (M): 2,053 @ $0 · Option exercise (M): 2,873 @ $0 · Option exercise (M): 2,053 (derivative) @ $0 · Option exercise (M): 2,873 (derivative) @ $0 | EDGAR |
| 2022-02-23 | 4 | Axcella Health Inc. (AXLA) | Option exercise (M): 1,534 · Option exercise (M): 1,534 (derivative) @ $0 | EDGAR |
| 2022-01-31 | 4 | Evelo Biosciences, Inc. (EVLO) | Option exercise (M): 2,052 @ $0 · Option exercise (M): 2,873 @ $0 · Option exercise (M): 2,052 (derivative) @ $0 · Option exercise (M): 2,873 (derivative) @ $0 | EDGAR |
| 2022-01-20 | 4 | Axcella Health Inc. (AXLA) | Option exercise (M): 1,535 · Option exercise (M): 1,535 (derivative) @ $0 | EDGAR |
| 2022-01-03 | 4 | Evelo Biosciences, Inc. (EVLO) | Option exercise (M): 2,052 @ $0 · Option exercise (M): 2,874 @ $0 · Option exercise (M): 2,052 (derivative) @ $0 · Option exercise (M): 2,874 (derivative) @ $0 | EDGAR |
| 2021-12-20 | 4 | Axcella Health Inc. (AXLA) | Option exercise (M): 1,535 · Option exercise (M): 1,535 (derivative) @ $0 | EDGAR |
| 2021-12-01 | 4 | Evelo Biosciences, Inc. (EVLO) | Option exercise (M): 2,053 @ $0 · Option exercise (M): 2,873 @ $0 · Option exercise (M): 2,053 (derivative) @ $0 · Option exercise (M): 2,873 (derivative) @ $0 | EDGAR |
| 2021-11-22 | 4 | Axcella Health Inc. (AXLA) | Option exercise (M): 1,534 · Option exercise (M): 1,534 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1445826 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs